Marianna Mancini - Dec 30, 2022 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Chief Operating Officer
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Dec 30, 2022
Transactions value $
-$398,532
Form type
4
Date filed
1/4/2023, 05:24 PM
Previous filing
Feb 11, 2022
Next filing
Jan 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +23.5K +9.41% $0.00 273K Dec 30, 2022 Direct F1, F2
transaction VKTX Common Stock, par value $0.00001 per share Tax liability -$120K -12.8K -4.67% $9.40 261K Dec 30, 2022 Direct F3
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +90.7K +34.8% $0.00 351K Jan 3, 2023 Direct F4
transaction VKTX Common Stock, par value $0.00001 per share Tax liability -$161K -18.9K -5.37% $8.52 332K Jan 3, 2023 Direct F5
transaction VKTX Common Stock, par value $0.00001 per share Tax liability -$118K -14K -4.21% $8.42 318K Jan 4, 2023 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Award $0 +204K $0.00 204K Jan 3, 2023 Common Stock 204K $8.52 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 66.67% of which vested on December 30, 2022 upon the achievement of two non-financial performance goals and a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on December 30, 2022 upon the achievement of a non-financial performance goal.
F2 Includes 4,545 shares acquired on May 20, 2022 and 6,566 shares acquired on November 18, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan
F3 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units.
F4 Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
F5 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.
F6 25% of the shares subject to the option will vest on each anniversary of the grant date.